+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Different Roles for the Pituitary and Adrenal Cortex in the Control of Enkephalin Peptide Localization and Cortico-Medullary Interaction in the Sheep Adrenal during Development

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          We have investigated the effect of adrenocorticotrophic hormone (ACTH) replacement after fetal hypophysectomy on the pattern of localization of enkephalin-containing peptides (enkephalins) and phenylethanolamine N-methyltransferase (PNMT) in the fetal sheep adrenal. We have also investigated the relative roles of the fetal pituitary and adrenal cortex in determining the extent of the interdigitation of the peripheral adrenaline (AD)-containing cells of the adrenal medulla with the inner zones of the adrenal cortex in the late gestation fetus. Fetal hypophysectomy (Hx; n = 12) or sham operations (n = 8) were performd at 109–118d. At 138 or 139d, ACTH (1–24) (10.5 µg/h) was infused intravenously for 72 h into 4 Hx fetuses (Hx + ACTH group). Saline was infused for 72 h into 4 Hx fetuses (Hx + Sal) and into 4 sham-operated fetal sheep (Intact + Sal). Fetal adrenal glands were collected at autopsy from 141/2d Intact + Sal, Hx + Sal and Hx + ACTH groups, from 4 intact fetal sheep at 145–147d gestation (145/7d Intact group) and 4 Hx fetal sheep at 147–164d gestation (147/64d Hx group). Adrenals were also collected from 4 newborn lambs at 10–12d afterbirth (10/12d Newborn group). Using the peroxidase-antiperoxidase immunocytochemical staining method, sections of adrenal glands (10–12 µm) from all groups were stained anti-PNMT. Sections of adrenal glands from the 141/2d groups were also stained separately with anti-dopamine-β-hydroxylase (anti-DβH) and anti-enkephalin (anti-ENK). Morphometric analyses were carried out on mid-glandular sections stained with anti-PNMT and an index of the interdigitation between the adrenal cortex and adrenal medulla was calculated (i.e. interdigitation index = the ratio of the perimeter of the adrenal medulla to the perimeter of a circle of the same area as the adrenal medulla). In the 141/2dHx + Sal and the 141/2dHx + ACTH groups, more central adrenomedullary cells were stained with anti-PNMT than in the intact group. In the 141/2d Intact + Sal group, staining with anti-ENK was observed in the peripheral rim of adrenal medulla cells which were adjacent to and interdigi-tated with the cells of the adrenal cortex. In the intact and Intact + SAL group, the intensity of staining with anti-ENK in the central noradrenaline (NA)-containing region was variable with many unstained cells present. In the 141/2d Hx + Sal and Hx + ACTH groups, however, staining for enkephalins was present throughout the entire adrenal medulla. The interdigitation index of the adrenal medulla and the adrenal cortex was significantly increased in the 10/ 12d Newborn (3.00 ± 0.07), 145/7d Intact (2.68 ± 0.07), and the 141/2d Hx + ACTH (2.62 ± 0.06) when compared to the 147/64d Hx (1.42 ± 0.03), 141/2d Intact + Sal (1.29 ± 0.02) and 141/2d Hx + Sal (1.15 ± 0.01) groups (p < 0.05). When the data were combined for all fetal and newborn lamb adrenals there was a positive correlation between the area of the adrenal cortex and the interdigitation index (r = 0.802; P < 0.001). In summary, we found that the pattern of localization of the enkephalins and PNMT in the fetal adrenal was similar in the 141/2d Hx + Sal and Hx + ACTH groups, therefore it would appear that the pituitary does not act via the adrenal cortex to suppress proENK A and PNMT gene expression in the centre of the adrenal medulla in the late gestation sheep fetus. The adrenal cortex, however, influences the extent of interdigitation between the peripheral rim of AD containing cells and the inner zone of the adrenal cortex, in the sheep adrenal gland during development.

          Related collections

          Author and article information

          S. Karger AG
          04 April 2008
          : 53
          : 3
          : 281-286
          Department of Physiology, Monash University, Clayton, Australia
          125730 Neuroendocrinology 1991;53:281–286
          © 1991 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Original Paper


          Comment on this article